Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors
Advanced Materials · 2024-07 · 36 (28)
DOI: 10.1002/adma.202313212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 06.05.2024. Verfasst von Zongheng Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong, 510515, China. Hauptthemen laut MEDLINE: Camptothecin, Copper, Neoplastic Stem Cells. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation of China, Guangzhou Key Research and Development Program of China.
Abstract (Originalsprache)
Cancer stem cells (CSCs) are one of the determinants of tumor heterogeneity and are characterized by self‐renewal, high tumorigenicity, invasiveness, and resistance to various therapies. To overcome the resistance of traditional tumor therapies resulting from CSCs, a strategy of double drug sequential therapy (DDST) for CSC‐enriched tumors is proposed in this study and is realized utilizing the developed double‐layered hollow mesoporous cuprous oxide nanoparticles (DL‐HMCONs). The high drug‐loading contents of camptothecin (CPT) and all‐trans retinoic acid (ATRA) demonstrate that the DL‐HMCON can be used as a generic drug delivery system. ATRA and CPT can be sequentially loaded in and released from CPT3@ATRA3@DL‐HMCON@HA. The DDST mechanisms of CPT3@ATRA3@DL‐HMCON@HA for CSC‐containing tumors are demonstrated as follows: 1) the first release of ATRA from the outer layer induces differentiation from CSCs with high drug resistance to non‐CSCs with low drug resistance; 2) the second release of CPT from the inner layer causes apoptosis of non‐CSCs; and 3) the third release of Cu + from DL‐HMCON itself triggers the Fenton‐like reaction and glutathione depletion, resulting in ferroptosis of non‐CSCs. This CPT3@ATRA3@DL‐HMCON@HA is verified to possess high DDST efficacy for CSC‐enriched tumors with high biosafety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong, 510515, China.
- Medical Imaging Center, Nanfang Hospital, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong, 510515, China.
- Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Singapore.
ORCID-Profile: Zheyu Shen
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Natural Science Foundation of China
- Guangzhou Key Research and Development Program of China
Zitieren
APA
Li, Z., Yang, J., Ren, B., Fan, Q., Huang, L., Guo, S., Zhou, R., Chen, S., Feng, J., Yan, C., Chen, X., & Shen, Z. (2024). Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors. Advanced Materials, 36(28). https://doi.org/10.1002/adma.202313212
Vancouver
Li Z, Yang J, Ren B, Fan Q, Huang L, Guo S, et al. Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors. Advanced Materials. 2024;36(28). doi:10.1002/adma.202313212
BibTeX
@article{Li2024,
author = {Li, Zongheng and Yang, Jing and Ren, Bin and Fan, Qingdeng and Huang, Lin and Guo, Shuai and Zhou, RuiLong and Chen, Sijin and Feng, Jie and Yan, Chenggong and Chen, Xiaoyuan and Shen, Zheyu},
title = {Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {28},
doi = {10.1002/adma.202313212}
}
EUVIMED